Murphi.ai vs ArteraAI
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
Murphi.ai compared with ArteraAI
| Detail | 
Murphi.ai | 
ArteraAI |
|---|
| What it does | AI platform for home health and hospice that reduces administrative work so clinicians and staff can spend more time on patient care
| Personalized precision medicine powered by AI for cancer therapy
|
|---|
| Stage | Not given
| Not given
|
|---|
| Founded | Not given
| Not given
|
|---|
| Based in | US
| US
|
|---|
| Pricing model | Contact for pricing
| Contact for pricing
|
|---|
| Pricing | Not given
| Not given
|
|---|
| Key features | - Ambient AI visit capture with automatic OASIS, HOPE and visit note generation
- Handwritten note upload and medication scanning
- 99% charting accuracy with AI-to-human review workflow
- AI-powered coding and OASIS review with 98% accuracy
- Care team collaboration through secure messaging
- Patient SMS engagement with secure text communication
- Patient payment collection via text-to-pay with EHR reconciliation
- Revenue assurance and claims management automation
- White-label deployment for EHR and healthcare platforms
- Offline visit recording with automatic upload on reconnection
| - Analyzes digital pathology with no additional tissue staining required
- Rapid results within 1-2 days after specimen receipt
- Validated across diverse populations including African American and non-African American men
- FDA De Novo authorization for prostate cancer risk stratification
- Insurance coverage for Medicare and many commercial plans
- Provides 5 and 10-year distant metastasis risk for breast cancer
- Identifies breast cancer patients who benefit from chemotherapy
- Included in NCCN Clinical Practice Guidelines for Prostate Cancer
|
|---|
| What makes it different | - 4–6 hours saved per clinician daily through ambient AI documentation
- 10–20% potential revenue increase through accurate coding and compliance
- Purpose-built for post-acute care workflows and OASIS compliance
- Integrates with existing EHR systems without requiring system replacement
- Human-guided AI with clinician review and approval for every output
| - No additional tissue preparation needed, uses existing H&E slides
- Validated across multiple large randomized phase III clinical trials
- FDA De Novo clearance as Software as a Medical Device
- Financial assistance program to make tests affordable regardless of income
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 25 ● no change since last check | 57 ● no change since last check |
|---|
| Trust Flow (Majestic) | 20 | 15 |
|---|
| Citation Flow (Majestic) | 34 | 27 |
|---|
| Referring domains (Majestic) | 425 | 285 |
|---|
5 details filled in for both companies.
More alternatives to Murphi.ai More alternatives to ArteraAI